Hemorrhagic Shock Activation of NLRP3 Inflammasome in Lung Endothelial Cells

Hemorrhagic shock (HS) due to major trauma and surgery predisposes the host to the development of systemic inflammatory response syndrome (SIRS), including acute lung injury (ALI), through activating and exaggerating the innate immune response. IL-1β is a crucial proinflammatory cytokine that contributes to the development of SIRS and ALI. Lung endothelial cells (EC) are one important source of IL-1β, and the production of active IL-1β is controlled by the inflammasome. In this study, we addressed the mechanism underlying HS activation of the inflammasome in lung EC. We show that high mobility group box 1 acting through TLR4, and a synergistic collaboration with TLR2 and receptor for advanced glycation end products signaling, mediates HS-induced activation of EC NAD(P)H oxidase. In turn, reactive oxygen species derived from NAD(P)H oxidase promote the association of thioredoxin-interacting protein with the nucleotide-binding oligomerization domain-like receptor protein NLRP3 and subsequently induce inflammasome activation and IL-1β secretion from the EC. We also show that neutrophil-derived reactive oxygen species play a role in enhancing EC NAD(P)H oxidase activation and therefore an amplified inflammasome activation in response to HS. The present study explores a novel mechanism underlying HS activation of EC inflammasome and thus presents a potential therapeutic target for SIRS and ALI induced after HS.

[1]  Y. Vodovotz,et al.  Hemorrhagic shock activates lung endothelial reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase via neutrophil NADPH oxidase. , 2011, American journal of respiratory cell and molecular biology.

[2]  M. Lamkanfi Emerging inflammasome effector mechanisms , 2011, Nature Reviews Immunology.

[3]  E. Mazzon,et al.  Effect of apocynin, a NADPH oxidase inhibitor, on acute lung inflammation. , 2011, Biochemical pharmacology.

[4]  J. Tschopp,et al.  NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? , 2010, Nature Reviews Immunology.

[5]  J. Tschopp,et al.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation , 2010, Nature Immunology.

[6]  Y. Vodovotz,et al.  Hemorrhagic shock augments lung endothelial cell activation: role of temporal alterations of TLR4 and TLR2. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[7]  A. Sauaia,et al.  HMGB1 IS MARKEDLY ELEVATED WITHIN 6 HOURS OF MECHANICAL TRAUMA IN HUMANS , 2009, Shock.

[8]  Y. Vodovotz,et al.  Interacting Neuroendocrine and Innate and Acquired Immune Pathways Regulate Neutrophil Mobilization from Bone Marrow following Hemorrhagic Shock1 , 2009, The Journal of Immunology.

[9]  J. Tschopp,et al.  Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica , 2008, Science.

[10]  T. Billiar,et al.  Early events in the recognition of danger signals after tissue injury , 2008, Journal of leukocyte biology.

[11]  K. Tracey,et al.  IL-1α and IL-1β Are Endogenous Mediators Linking Cell Injury to the Adaptive Alloimmune Response1 , 2007, The Journal of Immunology.

[12]  F. Martinon,et al.  Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration , 2007, Cell Death and Differentiation.

[13]  Y. Vodovotz,et al.  NEUTROPHIL NAD(P)H OXIDASE IS REQUIRED FOR HEMORRHAGIC SHOCK-ENHANCED TLR2 UP-REGULATION IN ALVEOLAR MACROPHAGES IN RESPONSE TO LPS , 2007, Shock.

[14]  K. Tracey,et al.  Hemorrhagic Shock Induces NAD(P)H Oxidase Activation in Neutrophils: Role of HMGB1-TLR4 Signaling1 , 2007, The Journal of Immunology.

[15]  E. Chavakis,et al.  A novel pathway of HMGB1‐mediated inflammatory cell recruitment that requires Mac‐1‐integrin , 2007, The EMBO journal.

[16]  K. Tracey,et al.  Anti-HMGB1 Neutralizing Antibody Ameliorates Gut Barrier Dysfunction and Improves Survival after Hemorrhagic Shock , 2006, Molecular medicine.

[17]  Y. Vodovotz,et al.  Hemorrhagic shock-activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macrophages: role in hemorrhage-primed lung inflammation. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[18]  E. Abraham,et al.  High mobility group box 1 protein interacts with multiple Toll-like receptors. , 2006, American journal of physiology. Cell physiology.

[19]  M. Lotze,et al.  Hepatic Ischemia/Reperfusion Injury Involves Functional TLR4 Signaling in Nonparenchymal Cells1 , 2005, The Journal of Immunology.

[20]  I. Douglas,et al.  HMGB1 contributes to the development of acute lung injury after hemorrhage. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[21]  K. Tracey,et al.  The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion , 2005, The Journal of experimental medicine.

[22]  M. Lotze,et al.  Addicted to Death: Invasive Cancer and the Immune Response to Unscheduled Cell Death , 2005, Journal of immunotherapy.

[23]  C. Roussos,et al.  Pulmonary endothelium in acute lung injury: from basic science to the critically ill , 2004, Intensive Care Medicine.

[24]  J. D. Di Santo,et al.  NK Cells and Polymorphonuclear Neutrophils Are Both Critical for IL-2-Induced Pulmonary Vascular Leak Syndrome1 , 2004, The Journal of Immunology.

[25]  Polly Matzinger,et al.  Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses , 2004, Nature Reviews Immunology.

[26]  U. Andersson,et al.  Mini‐review: The nuclear protein HMGB1 as a proinflammatory mediator , 2004, European journal of immunology.

[27]  E. Abraham,et al.  Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein* , 2004, Journal of Biological Chemistry.

[28]  K. Tracey,et al.  Reversing established sepsis with antagonists of endogenous high-mobility group box 1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Frey,et al.  TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase. , 2003, The Journal of clinical investigation.

[30]  A. Ridley,et al.  Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. , 2002, Cancer research.

[31]  F. Martinon,et al.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.

[32]  M. Freichel,et al.  Impairment of Store-Operated Ca2+ Entry in TRPC4−/− Mice Interferes With Increase in Lung Microvascular Permeability , 2002, Circulation research.

[33]  P. Matzinger The Danger Model: A Renewed Sense of Self , 2002, Science.

[34]  K. Tracey,et al.  HMGB1 as a late mediator of lethal systemic inflammation. , 2001, American journal of respiratory and critical care medicine.

[35]  M. J. Cotter,et al.  A novel method for isolation of neutrophils from murine blood using negative immunomagnetic separation. , 2001, The American journal of pathology.

[36]  B. Babior The NADPH Oxidase of Endothelial Cells , 2000, IUBMB life.

[37]  K. Tracey,et al.  High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes , 2000, The Journal of experimental medicine.

[38]  L. Moldawer,et al.  ANTICYTOKINE THERAPIES FOR ACUTE INFLAMMATION AND THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME: IL‐10 AND ISCHEMIA/REPERFUSION INJURY AS A NEW PARADIGM , 2000, Shock.

[39]  D. Sorescu,et al.  NAD(P)H oxidase: role in cardiovascular biology and disease. , 2000, Circulation research.

[40]  K. Tracey,et al.  HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.

[41]  H. Huttunen,et al.  Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling Pathways* , 1999, The Journal of Biological Chemistry.

[42]  E. Abraham,et al.  Why immunomodulatory therapies have not worked in sepsis , 1999, Intensive Care Medicine.

[43]  A. Al-Mehdi,et al.  Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+. , 1998, Circulation research.

[44]  J. Marshall,et al.  Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. , 1998, Journal of immunology.

[45]  S. Opal,et al.  Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. , 1997, Critical care medicine.

[46]  J. Chen,et al.  The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin , 1995, The Journal of Biological Chemistry.

[47]  R. Goris,et al.  Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt trauma. , 1995, Critical care medicine.

[48]  S. Lowry,et al.  Role of interleukin-1 and the therapeutic potential of interleukin-1 receptor antagonist in sepsis. , 1994, Circulatory shock.

[49]  S. Opal,et al.  Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. , 1994, JAMA.

[50]  R. F. Johnston,et al.  Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial , 1994 .

[51]  R. Shenkar,et al.  Hemorrhage and resuscitation induce alterations in cytokine expression and the development of acute lung injury. , 1994, American Journal of Respiratory Cell and Molecular Biology.

[52]  R. Sauerwein,et al.  Cytokine Patterns in Patients After Major Vascular Surgery, Hemorrhagic Shock, and Severe Blunt Trauma Relation with Subsequent Adult Respiratory Distress Syndrome and Multiple Organ Failure , 1993, Annals of surgery.

[53]  R. Shenkar,et al.  Effects of hemorrhage on cytokine gene transcription. , 1993, Lymphokine and cytokine research.

[54]  M. Glauser,et al.  Septic shock: pathogenesis , 1991, The Lancet.

[55]  E. Abraham,et al.  Effects of hemorrhage on interleukin-1 production. , 1988, Circulatory shock.

[56]  T. Petty,et al.  Adult respiratory distress syndrome: risk with common predispositions. , 1983, Annals of internal medicine.

[57]  J. Tschopp,et al.  The Inflammasomes , 2010, Cell.

[58]  K. Tracey,et al.  IL-1alpha and IL-1beta are endogenous mediators linking cell injury to the adaptive alloimmune response. , 2007, Journal of immunology.

[59]  K. Tracey,et al.  Targeting high mobility group box 1 as a late-acting mediator of inflammation. , 2003, Critical care medicine.

[60]  I. Chaudry,et al.  Cytokine gene expression in splenic macrophages and Kupffer cells following haemorrhage. , 1995, Cytokine.

[61]  A. Ellrodt,et al.  Sepsis and septic shock. , 1986, Emergency medicine clinics of North America.